No consensus on the indications for surgical resection of colorectal liver metastases exists.
This systematic review has been undertaken to assess the published evidence for its …

Background: Surgical resection is the only potentially curative treatment for colorectal liver
metastases, with 5‐year survival rates approaching 40 per cent. However, at present only 20 …

Aims The purpose of this meta-analysis is to assess the value of peri-operative
chemotherapy for patients who have resectable colorectal cancer with liver metastases …

Introduction: Surgical resection is presently the only approach that offers patients with liver
metastases from colorectal carcinoma substantial chance of cure. This article summarizes …

Approximately 50% to 60% of patients with colorectal cancer will develop hepatic
metastases during the course of their illness, with 20% to 30% of patients having liver …

Patients with cancer recurrence limited to the liver alone after a first liver resection may be
candidates for a repeat resection. Some 191 second and ten third liver resections for …

Background and aims: The liver represents the predominant site of cancer relapse after
curative resection of hepatic metastases from colorectal carcinoma. Adjuvant intra-arterial …

The aim of this study was to analyze the prognostic value of TP53 mutations in a consecutive
series of patients with hepatic metastases (HMs) from colorectal cancer undergoing surgical …

Resection of liver metastases in patients with colon cancer increases survival but success
depends on removal of all tumour tissue. For this purpose, understanding of spatial …

Colorectal cancer (CRC) is a leading cause of cancer death in the United States. More than
140,000 patients were diagnosed with CRC in 2004 [1]. It has been reported that between …